ALKBH5 and nonpapillary renal cell carcinoma: Survival analysis demonstrated that patients with higher ALKBH5 expression had poorer OS and RFS (Fig. 3F, G), and Cox analysis further confirmed ALKBH5 was an independent prognostic factor for the survival and recurrence of ccRCC patients (Tables 2 and 3).